XASX
PKY
Market cap4mUSD
Sep 22, Last price
0.02AUD
Name
Opyl Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in St Kilda, Australia, Opyl Limited, originally incorporated in 1994 as ShareRoot Limited before its rebranding in December 2019, specializes in developing digital innovations that significantly improve the healthcare journey for Australian patients. The company also offers valuable market intelligence gleaned from social media data and works to optimize clinical research procedures. Among its key offerings is Opin, an advanced platform for recruiting participants into clinical trials, which effectively connects patients with appropriate studies by utilizing social media, search engine optimization, and artificial intelligence. Additionally, Opyl provides comprehensive social media marketing agency services, including client and account management, specifically catering to the pharmaceutical, medical technology, and biotechnology industries.
Key people
Michelle Gallaher
Chief Executive Officer · since 2019
Misha McPherson
Chief Operating Officer · since 2016
Erik Norum
Exploration Manager
Jason Weaver
Chief Product Officer · since 2017
David Hwang
Company Secretary · since 2019
David Lilja
Company Secretary · since 2019
Julian Chick
Chairman of the Board · since 2019
Marat Basyrov
Non-Executive Director · since 2019
Damon Rasheed
Non-Executive Director · since 2019
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||